CVRx sees Q1 revenue $12.3M, consensus $14.68M

As of March 31, the company had a total of 227 active implanting centers in the U.S., as compared to 223 as of December 31, 2024. The number of sales territories in the U.S. decreased by 3 to a total of 45 during the three months ended March 31. As of March 31, cash and cash equivalents were $102.7M.